AU6111000A - Inhibitors of viral helcase - Google Patents

Inhibitors of viral helcase

Info

Publication number
AU6111000A
AU6111000A AU61110/00A AU6111000A AU6111000A AU 6111000 A AU6111000 A AU 6111000A AU 61110/00 A AU61110/00 A AU 61110/00A AU 6111000 A AU6111000 A AU 6111000A AU 6111000 A AU6111000 A AU 6111000A
Authority
AU
Australia
Prior art keywords
helcase
viral
inhibitors
viral helcase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61110/00A
Inventor
Christopher Baker
Michael Hale
James Janetka
Francois Maltais
Young Choon Moon
Jeffrey Saunders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of AU6111000A publication Critical patent/AU6111000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61110/00A 1999-07-22 2000-07-19 Inhibitors of viral helcase Abandoned AU6111000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14519399P 1999-07-22 1999-07-22
US60145193 1999-07-22
US15078399P 1999-08-26 1999-08-26
US60150783 1999-08-26
PCT/US2000/019650 WO2001007027A2 (en) 1999-07-22 2000-07-19 Pyrimidine derivatives for the treatment of viral diseases

Publications (1)

Publication Number Publication Date
AU6111000A true AU6111000A (en) 2001-02-13

Family

ID=26842750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61110/00A Abandoned AU6111000A (en) 1999-07-22 2000-07-19 Inhibitors of viral helcase

Country Status (2)

Country Link
AU (1) AU6111000A (en)
WO (1) WO2001007027A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4186484B2 (en) 2002-03-12 2008-11-26 住友化学株式会社 Pyrimidine compounds and uses thereof
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
WO2005019225A1 (en) * 2003-08-21 2005-03-03 Kyorin Pharmaceutical Co., Ltd. Process for producing compound having nk1 receptor antagonism and production intermediate thereof
JP4143669B2 (en) 2004-02-24 2008-09-03 日本たばこ産業株式会社 Four-ring condensed heterocyclic compounds and their use as HCV polymerase inhibitors
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
BRPI0617271A2 (en) * 2005-10-11 2011-07-19 Intermune Inc viral replication inhibitors
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
CA2670143A1 (en) * 2006-11-23 2008-05-29 Novartis Ag Pyrimidines and their use as cxcr2 receptor antagonists
EP2190826A2 (en) 2007-08-28 2010-06-02 Irm Llc 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
PE20091236A1 (en) 2007-11-22 2009-09-16 Astrazeneca Ab PYRIMIDINE DERIVATIVES AS IMMUNOMODULATORS OF TLR7
PE20100087A1 (en) 2008-06-25 2010-02-08 Irm Llc COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
US8445505B2 (en) 2008-06-25 2013-05-21 Irm Llc Pyrimidine derivatives as kinase inhibitors
JP5619743B2 (en) 2008-08-20 2014-11-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ethenyl substituted pyridine and pyrimidine derivatives and their use in the treatment of viral infections
TWI409265B (en) * 2008-08-20 2013-09-21 Merck Sharp & Dohme Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2326628A1 (en) 2008-08-20 2011-06-01 Schering Corporation Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
AR072940A1 (en) 2008-08-20 2010-09-29 Schering Corp PIRIDINE AND PYRIMIDINE DERIVATIVES REPLACED WITH ETHYLLIN AND ITS USE IN THE TREATMENT OF VIRAL INFECTIONS
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
SG175796A1 (en) 2009-05-21 2011-12-29 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
CA2777741A1 (en) * 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
WO2012080728A1 (en) 2010-12-16 2012-06-21 Astrazeneca Ab Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
WO2012113920A1 (en) 2011-02-24 2012-08-30 Katholieke Universiteit Leuven Arylsulfone derivatives with activity against human betaherpesviruses
MX2014014031A (en) 2012-05-18 2015-02-12 Sumitomo Dainippon Pharma Co Ltd Carboxylic acid compounds.
CN106496190A (en) * 2016-10-18 2017-03-15 北京瑞济善健康科技有限公司 New type NS 5B inhibitor and application thereof
CN107951887A (en) * 2016-10-18 2018-04-24 李文超 A kind of antiviral drugs
CN107954983A (en) * 2016-10-18 2018-04-24 陈利华 Pyrimidinones and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308272A (en) * 1980-10-03 1981-12-29 The Upjohn Company Process for treating hypertension
GB8410636D0 (en) * 1984-04-26 1984-05-31 Stevens M F G Pharmaceutical substances/compositions
US5256668A (en) * 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
IT1270122B (en) * 1994-10-04 1997-04-28 Ist Superiore Sanita 6-BENZYL-4-OXYPYRIMIDIN REPLACED, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1281502B1 (en) * 1995-06-13 1998-02-18 Sardinian Antiviral Research C USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF
GB9517022D0 (en) * 1995-08-19 1995-10-25 Glaxo Group Ltd Medicaments
IT1305313B1 (en) * 1998-07-17 2001-05-04 Colla Paolo 3,4 - DIHYDRO- 6- BENZYL-4-OXOPYRIMIDINE REPLACED AND RELATED PROCESS OF PRODUCTION AND USE IN THE THERAPY OF HIV-1 INFECTIONS.
MXPA01002253A (en) * 1998-09-04 2003-06-04 Viropharma Inc Methods for treating or preventing viral infections and associated diseases.

Also Published As

Publication number Publication date
WO2001007027A2 (en) 2001-02-01
WO2001007027A3 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU6111000A (en) Inhibitors of viral helcase
AU3867400A (en) Methods of using bioelastomers
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU5158100A (en) Inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
AU5283600A (en) Inhibitors of factor xa
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AUPP967999A0 (en) Viral variants
AU2001268701A1 (en) Methods of enhancing adhesion
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AU7126900A (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU2001292947A1 (en) Methods for inhibition of viral infection
AU2373600A (en) Novel spla2 inhibitors
AU2252101A (en) New synthesis of SPLA2 inhibitors
AU5433699A (en) Spacing of tiles
AU8005100A (en) Inhibitors of neuraminidases
AU7127000A (en) Enzyme inhibitors
AU7127100A (en) Enzyme inhibitors
AU7711800A (en) Novel uses of 2-bromopalmitate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase